Comparison Bupropion with srtraline on the depression in Parkinso

Phase 4

Recruiting

• Conditions: Condition 1: Depression. Condition 2: Parkinson.; Other depressive episodes; Parkinson's disease; F32.8

• Registration Number: IRCT20200513047429N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Parkinson's patients with major depression,

Exclusion Criteria

Absence history of other major neurological disorders, such as epilepsy, head trauma, vascular disorders, stroke and dementia, and other major psychiatric disorders, including bipolar disorder, schizophrenia, substance abuse, and use of Antipsychotics in the last 6 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of depression based on Beck's questionnaire. Timepoint: Measuring depression before intervention and then 1 and 3 month after intervention. Method of measurement: Beck's depression questionnaire.